Bio-Threats and Rapid Response INCELL is involved in work on several biothreat agents, including pandemics. These include human and animal pathogens: Influenza, Smallpox, Brucella, Coxiella, Salmonella, Yersinia, Others

Preventive countermeasures, such as vaccines, and rapid responses such as innovative manufacturing include process, research and product development, testing, and common goals with other vaccine development work:

• PLATFORM TECHNOLOGIES that can be reconfigured for rapid response to new or emerging biological threats or pathogens

• Rapid turnaround times based on a deep industry knowledge

• PLATFORM and “just-in-time” modular technologies, with innovative, rapid scale-up manufacturing

• Formulation, packaging, and delivery options that improve stability and shelf life to break the cold chain and/or accelerate distribution during a threat

• QA/QC processes and product development for reproducibility, stability, product analysis

• Bioassays, potency, purity and release testing

• In vitro and animal studies; GLP and pre-clinical

• Intellectual property

• COGS: Development of competitive products to be sold at a reasonable, but profitable cost